Role of Prokineticin in Epicardial Progenitor Cell Differentiation to Regenerate Heart

@inproceedings{Nebigil2012RoleOP,
  title={Role of Prokineticin in Epicardial Progenitor Cell Differentiation to Regenerate Heart},
  author={Canan G Nebigil},
  year={2012}
}
Over the last decade, stem/progenitor-cell therapy has emerged as an innovative approach to provide cardiac repair and regeneration (Zimmermann, et al., 2006). Several stemand progenitor-cell types from autologous and allogeneic donors have been analyzed to find the most appropriate candidate. Although embryonic stem (ES) cells can differentiate into most cardiac cell types (Mummery, et al., 2002) , their clinical use is severely limited due to ethical concerns and immunogenic and teratogenic… CONTINUE READING

Figures, Tables, and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 85 REFERENCES

EG-VEGF and the concept of tissue-specific angiogenic growth factors.

  • Seminars in cell & developmental biology
  • 2002
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The epicardium as a candidate for heart regeneration.

  • Future cardiology
  • 2012
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…